Brief: ADMA Biologics Reports Q4 Loss Per Share Of $0.18

ADMA Biologics

12/03/2020 22:01

March 12 (Reuters) - ADMA Biologics Inc  ADMA.O :
    * ADMA BIOLOGICS REPORTS FOURTH QUARTER AND FULL YEAR 2019
FINANCIAL RESULTS AND HIGHLIGHTS RECENT COMPANY PROGRESS
    * Q4 LOSS PER SHARE $0.18
    * Q4 REVENUE $12 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$10.4
MILLION
    * Q4 EARNINGS PER SHARE ESTIMATE $-0.17 -- REFINITIV IBES
DATA

Source text for Eikon:  ID:nGNX7qRS9V 
Further company coverage:  ADMA.O 

 ((Reuters.Briefs@thomsonreuters.com;))